BRANDIE QUICK: Open Payments
NPI 1558956086 · PUEBLO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$643 in 24 payments from 7 companies in 2025. Trend: 2023 $195 · 2024 $245 · 2025 $643
Food & beverage: $643
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $211 |
| Novo Nordisk Inc | 5 | $188 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $97 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $48 |
| ABBVIE INC. | 2 | $45 |
| Lilly USA, LLC | 2 | $33 |
| Henry Schein, Inc. | 1 | $21 |
Products named: REXULTI, Ozempic, CAPLYTA, XIFAXAN, Wegovy, MOUNJARO, QULIPTA, VRAYLAR.
Industry payments across CO — which companies pay providers there.
